If your triptan is not reliably working, you are in recognised company and there is a defined clinical path forward. Insufficient efficacy or tolerability with triptans affects roughly 30–40% of people who take them, and "triptan resistance" has a formal definition in headache medicine. What determines whether your next appointment is productive is largely whether you arrive with data — because "it doesn't really work" is a much weaker starting point than "it gave me relief at 2 hours in 3 of my last 12 attacks, and the failures were the ones where I dosed after nausea started."
How Common Non-Response Actually Is
A systematic literature review of patients with insufficient efficacy or tolerability to triptans found insufficient response in roughly 30–40% of people. The 2-hour pain-relief rate for oral triptans in trials tops out around 70%, so a substantial minority not responding is expected, not anomalous.
Cross-sectional data from the DMKG Headache Registry puts numbers on the more severe end in specialist care: 42.5% had failed at least one triptan, 13.1% had failed two or more — meeting the European Headache Federation definition of triptan resistance — and 3.9% had failed three or more.
One finding is worth knowing before you assume the answer is another triptan: people who respond well typically do so with their first triptan, and relatively few become responders after further switches. Switching is still a reasonable step, but it is not the only one, and the evidence does not suggest working through the whole class indefinitely.
Before Concluding the Drug Has Failed
Several things mimic drug failure. Worth ruling out first, because each has a different fix:
- Dosing too late. Acute treatment works best taken early. If your earliest reliable signal is neck stiffness or yawning rather than pain, that is when the window opens.
- Nausea at the time of dosing. Gastric emptying slows during attacks, which delays absorption — and nausea at dosing predicts poorer triptan response. See migraine nausea and what to discuss with your doctor.
- Allodynia already established. Once touch hurts, the attack has typically progressed past the point where acute treatment does its best work.
- Medication-overuse headache. Frequent acute use can sustain the cycle it is meant to break. Check your medication-use days.
- Headache recurrence rather than non-response. Relief that arrives then fades within 24 hours is a different problem from relief that never arrives, and is managed differently.
That last distinction is the one most often lost in describing the problem, and it changes the clinical answer.
What Your Doctor Will Want to Know
These are the fields that map onto how acute treatment response is actually assessed:
- Pain freedom at 2 hours — the standard trial endpoint, and the one to record.
- How many attacks you have treated with this triptan, at what dose.
- Whether you re-dosed, and whether that helped.
- Recurrence within 24 hours, yes or no.
- Side effects, and whether they are the reason you avoid taking it.
- Time from onset to dose, which is often the actual variable.
Options they may raise include a different triptan, a non-oral formulation, adding an antiemetic, newer acute drug classes such as gepants or ditans, or — if attacks are frequent — shifting the focus to prevention. Our migraine medication ladder and comparison of acute versus preventive treatment cover how these fit together. Which is appropriate depends on your history and other conditions; this is an agenda for the conversation, not a plan to act on alone.
Important Safety Note
Do not exceed the prescribed dose or dosing frequency of a triptan, and do not combine triptans without medical advice. Seek emergency care for chest pain, chest tightness, jaw or arm pain, shortness of breath, or slurred speech after taking a triptan. Triptans are not suitable for everyone — including some people with cardiovascular disease, uncontrolled high blood pressure, or certain migraine subtypes such as hemiplegic migraine — so any change to your acute treatment should be made with your prescriber. Seek urgent care for a headache that is the worst you have ever had, peaks within seconds, or comes with fever and neck stiffness, weakness, vision loss or confusion.
This article is educational and is not a substitute for individual medical advice.
What to Track
Twelve treated attacks is usually enough to turn an impression into evidence:
| Field | Why |
|---|---|
| Time symptoms started | The reference point for everything else |
| Time you dosed | The gap is often the real variable |
| Nausea present when dosing? | Tests the absorption explanation |
| Allodynia already present? | Tests whether the window had closed |
| Pain-free at 2 hours? | The endpoint your doctor recognises |
| Recurrence within 24 hours? | Distinguishes recurrence from non-response |
| Side effects | Separates "ineffective" from "intolerable" |
Bring the totals, not the diary: "pain-free at 2 hours in 4 of 12; of the 8 failures, 6 were dosed more than 2 hours after onset" is a finding a clinician can act on immediately.
The medication effectiveness tracker records exactly these fields and compares response across attacks. Migraine Trail will collect them by voice during an attack — which matters here, because dose timing and nausea status are precisely the details memory loses — and turn them into a report you can hand over.
Sources
